Skip to main content

DeviceTalks is an essential meeting for entrepreneurs, engineers, and other professionals developing the latest tools used to treat patients and cure disease. DeviceTalks Boston will unite Medtech’s most innovative professionals find the quickest way to clear troublesome bottlenecks in these critical stages: innovation & funding; prototyping and product development; manufacturing & sourcing; regulatory, reimbursement and market development; and engineering tools & technology. GT Shareholders David Dykeman (BOS), Ginger Pigott (LA), and Libby Stennes (MSP) will be presenters during the session, "How COVID-19 is Creating New IP and Litigation Challenges for Medtechs." The session will discuss important and timely developments and trends including IP strategy for companies innovating new technology or forming new collaborations, liability risks and immunity protections, and the impact of COVID-19 on litigation in the medtech industry.